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Abstract
Background: Once considered as the main public health problem in developed countries, obesity has
become a major problem throughout the world and developing countries, like Iran, are joining the global
obesity pandemic. We determined the prevalence of overweight, obesity, and hypertension in a large
cohort of Iranians and compared age-adjusted rates with the rates in the US. 
Methods: Golestan Cohort Study is a population-based study of 8,998 men and women, aged 35-81 years,
from urban and rural areas. Anthropometric parameters were measured by interviewers. Prevalence rates
were directly adjusted to the 2000 United States standard population.
Results: The age-adjusted prevalence rates of overweight (BMI ≥ 25 kg/m2) and obesity (BMI ≥ 30 kg/m2)
in this Iranian population were 62.2% and 28.0%, respectively.  Both overweight and obesity were more
common in women than men. Age-adjusted prevalence of overweight was significantly higher in Iranian
women compared to the American women (68.6% vs. 61.6%), while the age-adjusted prevalence of obesity
is closer in these two populations (34.9% vs. 33.2%). Iranian men—compared to American men—had
significantly lower age-adjusted prevalence of overweight (53.7% vs. 68.8%) and obesity (16.2% vs. 27.5%).
Age-adjusted prevalence of hypertension was higher in Iranian women than American women (35.7% vs.
30.5%). Diabetes mellitus was reported in 6.2% of participants. Mean waist-to-hip ratio (WHR) among
women was 0.96. Smoking rates in men and women were 33.2% and 2.2%, respectively. 
Conclusion: The prevalence of obesity, overweight, and hypertension in Iran is as high as the US.
However, Iranian women are more obese than American women and Iranian men are less obese than their
American counterparts. This discrepancy might be due to the low rate of smoking among Iranian women.
Iranian women have higher mean WHR than what WHO has defined in 19 other populations.
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Background
Listing medical and health-related issues in the Middle
East, the first things that come to one's minds might be
problems like infectious diseases that are more common
in developing countries. However, by merely focusing on
specific types of endemic diseases in the region, we under-
mine significant problems like obesity and metabolic syn-
drome that might have equal or even greater impact on
the health of people in these countries. Although these
health issues are more discussed in developed countries,
we should notice that most Middle Eastern countries are
joining the global obesity pandemic and the problem
becomes more significant when we consider the trend in
developing countries toward the Western lifestyles. This
westernization can potentially put the population of these
countries at higher risk of obesity and metabolic syn-
drome than western countries. It is suggested that fetal
growth and maternal nutrition have crucial effects on epi-
genetic programming of obesity, metabolic syndrome,
diabetes, and hypertension [1-3] and in these countries
we are dealing with a generation born in more traditional
environment–and therefore more susceptible to obesity
and insulin resistance–who is exposed to high-calorie
foods and sedentary lifestyle. Failure of the scientific com-
munity in recognizing the problem will result in a Middle
East with an alarming situation like what we see in Pima
Indians in the US [4,5] or adults with prenatal exposure to
Dutch famine in Europe [6,7]. As Horton has highlighted,
we have an unusual opportunity to act in order to prevent
the needless deaths of millions by focusing on risk factors
of chronic diseases in low-income countries [8].
Obesity is a major medical and public health problem
world-wide and by consequences like type 2 diabetes mel-
litus and insulin resistance ultimately causes several
health conditions like cardiovascular and cerebrovascular
diseases, certain types of cancers, hypertension, gallblad-
der disease, nonalcoholic steatohepatitis, and obesity-
hypoventilation syndrome. In addition to overall obesity,
abdominal obesity is considered as independent predictor
of several risk factors and morbidity [9,10].
This paper estimates the prevalence of overweight, obes-
ity, and abdominal obesity in Iran using the da large
cohort study, the Golestan Cohort Study. The age-
adjusted and age-specific prevalence rates will be com-
pared to the rates in the United States. Considering the
association of obesity with metabolic syndrome, we esti-
mate the prevalence of hypertension and diabetes melli-
tus–two other criteria for metabolic syndrome and two
independent risk factors for many comorbid conditions–
in addition to obesity.
Methods
Study population
This study analyzes the data from the Golestan Cohort
Study, a large study that is conducted in North-East of
Iran. The study is an ongoing population-based cohort
with the main objective of investigating the incidence of
esophageal cancer and the associated risk factors. For this
analysis, we included data from 8,999 participants
recruited between 2002 and 2005. The study is sponsored
by Digestive Diseases Research Center (DDRC) at Tehran
University of Medical Sciences (Tehran, Iran), Interna-
tional Agency for Research on Cancer (IARC; Lyon,
France), and Golestan University of Medical Sciences,
Iran. One participant was excluded from the analysis
because his height was missing. The study adhered to the
Declaration of Helsinki [11] and was approved by the
Institutional Review Board of the DDRC.
Residents were selected by household sampling and con-
tacted at their home by expert local health professionals,
who thoroughly explained them the purpose and proce-
dure of the study. Individuals were invited to participate
by attending the health service centers located in their area
or the Golestan Cohort Study Center for interview. More
than 75% of rural subjects and 62% of urban subjects who
were invited to the study participated. Interviewers were
local physicians and, in the case of dietary interviews,
nutritionists who were trained for this purpose. Exclusion
criteria were: (1) being a temporary resident; and (2) pre-
vious history of upper gastrointestinal cancer.
Data collection
Before interview, a written informed consent was
obtained from all study participants. Detailed data con-
cerning alcohol consumption and smoking as well as
type, duration, and estimated amount of drinking/smok-
ing were collected. Demographic and anthropometric
data were collected on all participants. Weight (kg), height
(cm), waist and hip circumferences (cm) were measured
by interviewers and recorded with precision of one unit.
The values for weight were rounded to the nearest 0.5 kg
and height was rounded to the nearest 0.1 cm. Subjects
were wearing light clothes. Three anthropometric indices
that were analyzed in this study were body mass index
(BMI), waist-to-hip ratio (WHR), and waist circumference
(WC). BMI was calculated using the formula weight(kg)/
[height(m)]2 and WHR was defined as the ratio of waist
circumference (WC) to hip circumference. BMI is recog-
nized as the measure of overall obesity. A BMI ≥ 25 kg/m2
was defined as overweight and a BMI ≥ 30 kg/m2 was
defined as obesity. Individuals with BMI<18.5 kg/m2 were
considered as underweight. WHR and WC were used as
measures of abdominal obesity. A WHR ≥ 0.95 in men
and = 0.85 in women were considered as high WHRBMC Public Health 2006, 6:158 http://www.biomedcentral.com/1471-2458/6/158
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(abdominal obesity) [10]. Also, a WC>102 cm in men and
>88 cm in women were considered as high WC [9].
Two recordings of systolic and diastolic blood pressures
were obtained for each arm in sitting position. Hyperten-
sion was defined as any of these conditions: (1) average
systolic blood pressure ≥ 140 mmHg; (2) average diastolic
blood pressure ≥ 90 mmHg; (3) being known case of
hypertension (diagnosed by a physician) or receiving
medications for hypertension.
Diabetes mellitus was defined by self-report. A question-
naire including questions about different mild, moderate,
and strenuous physical activities were filled for all partici-
pants. Metabolic equivalent (MET) for various activities
was calculated based on an updated Compendium of
Physical Activities [12]. Data on calorie intake calculated
from food-frequency questionnaire (FFQ) was available
for 4,048 participants. Total daily calorie intake was calcu-
lated using a Food Processor© Nutrition Analysis Software
(Elizabeth Stuart Hands and Associates (ESHA) Research,
Salem, Oregon).
Statistical analysis
The data are presented as crude and adjusted prevalence
rates, standard errors, and 95% confidence intervals
(binomial exact confidence intervals). Prevalence rates
have been directly adjusted to the 2000 United States
standard population [13] using 5-year age groups. The
main reason for this adjustment was to compare the
results with the results of the Third National Health and
Nutrition Examination Survey (NHANES III) in the
United States [14]. Since the age range in our study popu-
lation was from 35 to 81 years, we considered one 81-
year-old and two 80-year-old participants in the age group
75–79.
Generalized linear regression model is used to estimate
predictors of BMI. We used logistic regression to deter-
mine the association of binary outcomes with independ-
ent covariates. Model assumptions and robustness of our
results to highly influential observations were checked
(using regression diagnostics, dbetas, and dfits). Data on
continuous variables are presented as mean ± standard
deviation (SD). Prevalence rates are presented as percent
and 95% confidence interval (CI). T test and chi-square
test have been used to compare numeric and categorical
variables, respectively. Data analyses were performed
using Stata® statistical software (Version 8.0, Stata Inc.,
College Station, TX).
Results
Prevalence of obesity and overweight
Excluding one individual whose height was missing from
the analysis, the study population consisted of 8,998 par-
ticipants (3,786 men and 5,212 women) with mean ± SD
age of 52.8 ± 9.4 years (range 35 to 81 years). Among
these participants, 5,182 individuals (57.6%) were from
urban population and 3,817 individuals (42.4%) were
from rural area. Table 1 summarizes the general character-
istics of the study population.
The overall prevalence of overweight (BMI ≥ 25 kg/m2)
was 63.5% (95% CI: 62.5%–64.5%). The prevalence of
overweight was slightly higher in younger age groups, but
it was significantly reduced after 65 years old (p-value for
trend < 0.01). The prevalence of overweight was signifi-
cantly (p-value < 0.01) higher in women than men
(69.7% vs. 54.9%).
The overall prevalence of obesity (BMI ≥ 30 kg/m2) was
28.4% (95% CI: 27.4%–29.3%). The pattern of change in
the prevalence of obesity across different age groups was
Table 1: Demographic and anthropometric characteristics of the participants in Golestan Cohort Study, Iran.
Demographic/Anthropometric Characteristics Men (N = 3,787) Women (N = 5,212)
Age (years) 53.7 (53.4–54.0) 52.2 (52.0 – 52.5)
Rural 41.7% 43.0%
Smoking Current Use 33.2% 2.2%
Ever Used 47.0% 2.6%
Alcohol Consumption Current Use 7.2% 0.1%
Ever Used 17.8% 0.1%
BMI (kg/m2) 25.8 (25.6–26.1) 28.6 (28.3–28.8)
BMI Categories Obesity (BMI = 30 kg/m2) 17.0% 36.7%
Overweight (25 = BMI <30 kg/m2) 38.0% 33.1%
Normal weight (18.5 = BMI<25 kg/
m2)
40.3% 26.8%
Underweight (BMI <18.5 kg/m2) 4.8% 3.5%
Waist Circumference (cm) 96.0 (95.6–96.4) 98.0(97.3–98.7)
Waist-to-Hip Ratio 0.96 (0.95–0.96) 0.96(0.95–0.97)BMC Public Health 2006, 6:158 http://www.biomedcentral.com/1471-2458/6/158
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similar to the prevalence of overweight. Women had a sig-
nificantly higher prevalence of obesity compared to men
(36.7% vs. 17.0%, p-value < 0.01).
Table 2 compares the unadjusted and adjusted prevalence
rates of obesity and overweight in this Iranian population
to the rates in the United States. Adjustments have been
performed in both populations to the 2000 US standard
population using 5-year age groups. The adjusted preva-
lence rates of overweight and obesity in this Iranian pop-
ulation were 62.2% and 28.0%, respectively. These rates
are very close to similar rates in the US population (65.1%
and 30.4%, respectively). However, gender-specific rates
demonstrate that the age-adjusted prevalence of over-
weight is significantly higher in Iranian women compared
to the American women (68.6% vs. 61.6%), while the age-
adjusted prevalence of obesity is closer in these two pop-
ulations (34.9% vs. 33.2%). On the contrary, Iranian men
have significantly lower age-adjusted prevalence of over-
weight (53.7% vs. 68.8%) and obesity (16.2% vs. 27.5%).
Figure 1 illustrates the gender- and age-specific prevalence
rates of obesity and overweight in these two populations.
As illustrated in this figure, Iranian men have higher prev-
alence of both obesity and overweight in all age-groups
shown in this figure, while Iranian women have higher
prevalence of obesity and overweight in lower age-groups,
which constitute considerable proportions of the popula-
tion (about 62% of the US population above 35 years old
in 2000 were in the age-groups 35 to 55, where Iranian
women have a significantly higher prevalence of obesity).
In the logistic regression model for both obesity and over-
weight, the significant difference between genders did not
change considerably after adjustment for age, education,
and smoking. The variables that were associated with
lower odds of obesity in the logistic regression model
were older ages, male gender, living in rural areas, lower
level of education, and smoking. Odds ratio (OR) of being
obese comparing females to males was 1.8 (95% CI: 1.6–
2.0). Ethnicity, alcohol consumption, and physical activ-
ity were not significant predictors of the obesity. Similar
results were obtained in the logistic regression model for
overweight. OR of being overweight comparing women to
men was 2.7 (95% CI: 2.4–3.1). The only difference was
that alcohol consumption was associated with higher
odds of being overweight. Linear regression model using
BMI as the outcome showed similar results, although the
association of alcohol consumption showed a week asso-
ciation with higher BMI (p-value: 0.095).
Overall prevalence rates of overweight among men and
women in rural areas were 50.1% and 64.6%, respectively,
while these rates in urban areas were 58.4% and 73.5%,
respectively. The prevalence rates of obesity among men
and women living in rural areas were 14.2% and 33.6%,
respectively, which were lower than the rates in urban
areas, 18.9% and 38.9%, respectively. There prevalence of
obesity and the factors associated with it were similar in
different ethnic groups.
High WHR was observed in 74.5% of the study popula-
tion (95% CI: 73.6%–75.4%). The prevalence rates of
high WHR were 54.7% (95% CI: 53.1%–56.3%) among
men and 88.9% (95% CI: 88.0%–89.7%) among women.
Since WHR is suggested to be independent risk factor of
cardiovascular diseases, we looked at the overlap between
Age-specific prevalence of obesity and overweight among Iranian and American participants of the Golestan Cohort Study and  Third National Health and Nutrition Examination Survey (NHANES III), respectively Figure 1
Age-specific prevalence of obesity and overweight among Iranian and American participants of the Golestan Cohort Study and 
Third National Health and Nutrition Examination Survey (NHANES III), respectively. Note: Error bars indicate 1.96*standard 
error.
0
10
20
30
40
50
60
70
80
90
35-44 45-54 55-64 65-74 75
Age (year)
P
r
e
v
a
l
e
n
c
e
 
(
%
)
Overweight among Iranian Men Overweight among American Men
Obesity among Iranian Men Obesity among American Men
0
10
20
30
40
50
60
70
80
90
35-44 45-54 55-64 65-74 75
Age (year)
P
r
e
v
a
l
e
n
c
e
 
(
%
)
Overweight among Iranian Women Overweight among American Women
Obesity among Iranian Women Obesity among American Women
Men WomenBMC Public Health 2006, 6:158 http://www.biomedcentral.com/1471-2458/6/158
Page 5 of 9
(page number not for citation purposes)
high WHR and high BMI. The overall percent agreement
and kappa statistic between high WHR and overweight
were 76.7% and 0.44 (standard error: 0.01), respectively.
About 49.8% of subjects with normal weight (18.5 ≤
BMI<25 kg/m2) had high WHR and 9.7% of overweight
participants had low WHR. The agreement between high
WHR and overweight was higher in men than in women
(kappa statistics: 0.58 and 0.27, respectively). In other
words, women have higher chance of having high WHR
even if they have normal weight. The other finding was
that 77.3 % of women with normal BMI had high WHR,
while only 4.3% of women with low WHR had high BMI.
These proportions were 24.8% and 19.1%, respectively,
among men. The similarity between these two propor-
tions among men brings about the rather similar preva-
lence rates of overweight and high WHR among men,
while prevalence of high WHR is significantly higher than
the prevalence of overweight among women.
About 80.7% of participants had either high BMI ≥ 25 kg/
m2 or high WHR (95% CI: 79.8%–81.5%). This rate was
65.2% (95% CI: 63.7%–66.7%) among men and 91.9%
(91.1%–92.6%) among women. High waist circumfer-
ence (more than 102 cm in men and 88 cm in women)
was observed in 58.4% of participants.
The aforementioned analyses were repeated in a subset of
the study population (4,408 consecutive participants who
have been recruited in the last half of the study) for whom
FFQ were filled and therefore data on daily calorie intake
were available. This subset of the population consisted of
1,731 males and 2,317 females with a mean age of 53.1 ±
9.4 years. All these participants were recruited during sec-
ond and third years of accrual. There was no association
between gender and daily calorie intake. In the logistic
regression model, participants in the highest tertile of
daily calorie intake had higher prevalence of overweight
compared to the participants in lower two tertiles (OR:
1.15, 95% CI: 1.00–1.33, p-value: 0.04). However, daily
calorie intake was not a significant predictor of obesity,
abdominal obesity (estimated by high WHR), and BMI in
the multivariate logistic and linear regression models.
Prevalence of hypertension and diabetes mellitus
Unadjusted Prevalence of hypertension was 32.5% (95%
CI: 31.6%–33.5%) and hypertension was more common
in women than men (OR: 1.2, 95% CI: 1.1–1.4). Table 3
compares the crude and adjusted prevalence of hyperten-
sion in our study with the results of NHANES III. While
unadjusted prevalence rate of hypertension in Iranian and
American women are rather similar, adjusted prevalence
rate of hypertension in Iranian women is significantly
higher than Americans. Mean BMI in participants with
and without hypertension was 27.6 and 27.3 kg/m2 (p-
value: 0.08). In logistic regression model, diabetes melli-
tus and female gender were the only risk factors associated
with hypertension. There was no significant association
between hypertension and body weight.
Table 2: Adjusted* and unadjusted prevalence rates of obesity and overweight in Golestan Cohort Study, Iran, and Third National 
Health and Nutrition Examination Survey (NHANES III), United States
Iran United States
Golestan Cohort 
Study
1999–2002 1988–1994
Unadjusted
Overweight
Overall 63.5 (0.5)† 65.2 (0.8) 54.9 (0.8)
Men 54.9 (0.8) 68.6 (0.9) 59.4 (1.0)
Women 69.7 (0.6) 62.0 (1.2) 50.7 (1.0)
Obesity
Overall 28.4 (0.4) 30.5 (0.9) 22.3 (0.6)
Men 17.0 (0.6) 27.5 (0.9) 19.5 (0.7)
Women 36.6 (0.7) 33.4 (1.2) 25.0 (0.9)
Adjusted
Overweight
Overall 62.2 (0.5) 65.1 (0.8) 56.0 (0.8)
Men 53.7 (0.8) 68.8 (0.9) 61.0 (1.0)
Women 68.6 (0.6) 61.6 (1.2) 51.4 (1.0)
Obesity
Overall 28.0 (0.4) 30.4 (0.9) 22.9 (0.7)
Men 16.2 (0.6) 27.5 (0.9) 20.2 (0.7)
Women 34.9 (0.7) 33.2 (1.2) 25.5 (0.9)
*Adjustments for age have been performed in both populations to the 2000 US standard population using 5-year age groups.
† Data presented as: percent (standard error)BMC Public Health 2006, 6:158 http://www.biomedcentral.com/1471-2458/6/158
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Diabetes mellitus was reported in 6.1% (95% CI: 5.7%–
6.7%) of participants. In logistic regression model, hyper-
tension and living in urban areas were only predictors of
diagnosed diabetes mellitus. Prevalence of diabetes melli-
tus in men and women was 4.4% and 7.4%, respectively.
In multivariable logistic regression model, odds of having
diagnosed diabetes mellitus in women was higher than
men (OR: 1.9; 95% CI: 1.5–2.3). Diabetic participants
had significantly higher BMI (p-value: 0.04).
Alcohol and smoking
Alcohol consumption rate was 7.5% (95% CI: 7.0%–
8.1%) and men had a significantly higher rates of alcohol
consumption comparing to women (17.8% and 0.1%,
respectively, p-value < 0.01).
Current smoking rates were 33.2% (95% CI: 32.4%–
34.0%) in men and 2.2% (95% CI: 2.0%–2.4%) in
women. Ever smoking rates in men and women were
47.0% and 2.6%, respectively. Adjusting for smoking in
multivariable logistic models for obesity and overweight
reduced the magnitude of the differences between gen-
ders.
Discussion
Once considered as the main public health problem of the
developed countries, obesity has become a major prob-
lem throughout the world and the prevalence of obesity is
increasing in most developing countries as well.
The first important finding of our study was that the esti-
mated overall prevalence of obesity in an Iranian popula-
tion is quite comparable to the US [14] and higher than
United Kingdom, France, Netherlands, and Italy [15-19].
These results are consistent with similar reports from Iran
[20-22] as well as other countries in Middle East [23-30].
Even some reports from some Middle Eastern countries
show a higher prevalence of obesity comparing to the US
[31]. While World Health Organization (WHO) has esti-
mated that the mean BMI in Africa and Asia is about 22–
23 Kg/m2 [32], the average BMI in our study as well as in
other studies in Middle East is similar to the North Amer-
ican and European countries. The increasing prevalence of
obesity has brought about the increase in myriad of public
health consequences in these countries. Currently, cardio-
vascular diseases (47%) and cancer (14%) account for
more than 60% of mortality in Iran [21].
One major concern in comparing our results with the
results of the NHANES III was the generalizability of these
findings to the total population in Iran. Our study was a
large population-based study and consisted of both urban
and rural populations. However, the study population
consisted of individuals older than 35 years old. In order
to address this limitation, we compared the age-specific
rates between Iranian and American populations. Also,
our study population had higher proportion of females
comparing to the total population of Iran. This might
have resulted in a slight overestimation of the prevalence
of obesity in Iranian general population. However, even if
we calculate the prevalence rate based on the male/female
ratio in the total population of Iran (approximately 1:1)
[33], the adjusted prevalence rate of overweight and obes-
ity will be 61.2% and 25.6%, respectively, which are still
comparable to the rates in the United States. In addition,
our results were consistent with the results of Tehran Lipid
and Glucose Study (TLGS), another large cohort study
that was carried out in urban population of the capital city
of Tehran [21]. In TGLS, 63.1% of the adult population
over 20 years old were overweight (BMI ≥ 25 kg/m2) and
23.1% of them were obese (Table 3). This consistency in
findings indicates a reasonable generalizability of our
results, although generalizability is still one of the limita-
tions of this study.
Since the standardized prevalence rates in the US popula-
tion are calculated using all age-groups, one of our con-
cerns was if the adjusted rates in US are affected by the
lower prevalence of obesity in lower age-groups. There-
fore, we calculated the truncated age-adjusted prevalence
of obesity and overweight in both populations (using the
population above 35 years old). Because the age-specific
Table 3: Adjusted* and unadjusted prevalence of hypertension in Golestan Cohort Study, Iran, and Third National Health and 
Nutrition Examination Survey (NHANES III), United States
Iran (Golestan Cohort Study) USA (NHANES III)
Unadjusted Overall 32.5 (0.5) † 30.1 (1.0)
Men 29.8 (0.7) 27.5 (1.2)
Women 34.5 (0.7) 32.7 (1.1)
Adjusted Overall 33.8 (0.5) 29.9 (0.8)
Men 29.4 (0.7) 28.7 (1.2)
Women 35.7 (0.7) 30.5 (0.7)
*Adjustments for age have been performed in both populations to the 2000 US standard population using 5-year age groups.
† Data presented as: percent (standard error)BMC Public Health 2006, 6:158 http://www.biomedcentral.com/1471-2458/6/158
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rates from NHANES III were available in 10-year intervals,
these rates are calculated using 10-year age intervals and
therefore, the results are slightly different from what
reported above. The truncated adjusted prevalence of
overweight in our study and in NHANES III was 53.7%
and 66.7%, respectively, among men and 68.8% and
57.3%, respectively, among women. Truncated adjusted
prevalence rates of obesity in Iranian men and women
were 16.1% and 36.2%, respectively, and these rates were
23.2% and 28.8% in American population.
The other important result of this study was the discrep-
ancy in gender distribution of obesity and overweight in
Iran comparing to the US. This discrepancy was also
observed in several other studies conducted in the Middle
East [21,23,25,29], although some studies have shown a
pattern close to what is observed in the United States [28].
As it is shown in Table 3, the results of TGLS were com-
pletely consistent with our results. In a study by Yumuk et
al [23], the prevalence of obesity among Turkish women
and men was 32.4% and 14.1%, respectively, while the
prevalence of overweight among men and women was
65.9% and 50.4%, respectively. In Saudi Arabia, the prev-
alence of obesity is estimated to be between 17–44% in
women and 13–26% in men [25-27,34] and in Egypt, the
prevalence of obesity ranges from 40.6% among women
living in urban areas to 6% among men living in rural
areas [29].
Therefore, although the overall prevalence of overweight
and obesity in Iranian population–as well as many other
Middle Eastern populations–is rather similar to the Amer-
ican population, Iranian women tend to be more obese
than American women and Iranian men are less obese
than their American counterparts. As explained above,
both our study and the TLGS demonstrated a significantly
higher prevalence of overweight and obesity among
women. We tested several hypotheses that could poten-
tially explain this difference. One hypothesis was that
probably these results are explained by differences in
physical activity or calorie intake. In other words, Iranian
women might have less physical activity and/or higher
calorie intake comparing to Iranian men and American
women. However, neither physical activity nor calorie
intake were significantly different between Iranian men
and women. Lack of association between gender and
physical activity or calorie intake reduces the probability
that the gender discrepancy in prevalence of obesity is due
to these factors. Since physical activity was estimated
using a different questionnaire, the direct comparison
between our results and the results of studies conducted in
developed countries was not possible. Although the total
calorie intake was not associated with gender and there-
fore has low probability of being a confounder, it is possi-
ble that differences in the dietary contents–rather than
total calorie intake–account for part of the discrepancy
between Iranian men and women as well as the discrep-
ancy between Iranian people and their American counter-
parts. Another hypothesis is the constitutional and
biological differences between two populations or resid-
ual confounding due to the factors that we have not meas-
ured in this study.
The strongest hypothesis that was supported by this study
is the difference in smoking habits. Smoking is shown to
be associated with lower BMI and even some authors have
suggested that decreasing rates of smoking in the US is
one of the important contributing factors to the rising
prevalence of obesity in the US [35]. Current smoking
rates among men and women in our study were 33.2%
and 2.2%, respectively, while these rates among American
men and women are 24.8% and 20.1%, respectively.
Therefore differences in smoking rates is consistent with
discrepancy between Iranian men and women as well as
the discrepancy between Iranian and American popula-
tion.
Other important results of our study were the prevalence
rates of hypertension and diabetes mellitus as two other
risk factor of cardiovascular diseases and two other criteria
of metabolic syndrome. Prevalence of hypertension in our
study was quite comparable with prevalence rates in the
US. Diabetes mellitus was measured based on self-report
and since a significant proportion of diabetic cases are not
clinical, our results significantly underestimates the prev-
alence of diabetes. Consequently, the interpretation of
our findings should be limited to the diagnosed cases of
diabetes. Prevalence of diabetes in this Iranian population
was slightly lower than the US population–with about 8%
prevalence of diabetes–and is higher than what is reported
in some neighboring countries, e.g. 3.4% in Turkey [23].
Other studies have shown that Iranian people have high
rates of high HDL-cholesterol as another criterion of met-
abolic syndrome. Azizi et al, have shown that in TLGS,
73% of participants had low HDL-cholesterol, which is
more than what had been previously reported in many
western countries [22].
The other finding that requires further elaboration is the
high prevalence of abdominal obesity in Iranian women.
While mean WHR in 19 populations studied in WHO
MONICA project [36] was from 0.87–0.99 in men and
from 0.76–0.84 in women, the mean WHR among men
and women in our study was 0.96 in both men and
women. The median WHR in Iranian women was 0.95,
while the median WHR in a Danish population was 0.80
[37]. Therefore, Iranian women have considerably higher
WHR comparing to other countries and as mentioned
above, a large proportion of women in our study popula-
tion had high WHR even with normal BMI. This might beBMC Public Health 2006, 6:158 http://www.biomedcentral.com/1471-2458/6/158
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due to genetic predisposition of Iranian women, lower
smoking rates, or differences in epigenetic programming
of Iranian women.
Prevalence of obesity and metabolic syndrome is increas-
ing in Iran. TLGS showed the trend in rising prevalence of
obesity and overweight in Tehran [38]. Considering the
constant increase in prevalence of obesity in both US and
Iran, Table 2 provides a rough estimate of where our
results fall within the trend of obesity in the US. Techno-
logical changes that has lowered both the real cost of food
and the level of physical activity [39], increased food con-
sumption [40], and decrease in smoking rate [35] are
among the reasons suggested for this trend. Also, as men-
tioned above, the transition toward a Western lifestyle has
put a population that is susceptible to obesity–due to fac-
tors like epigenetic programming–at high risk of obesity,
metabolic syndrome, and their consequences. The fact
that women in our study, comparing to American women,
showed significantly higher prevalence rates in lower age
groups is consistent with the latter hypothesis, as older
women have had been less affected by consequences of
industrialization.
Conclusion
Prevalence of obesity and overweight in Iran-as well as
other Middle Eastern countries–is as high as the United
States. However, Iranian women are more obese than
American women, while Iranian men are less obese than
their American counterparts. This discrepancy might be
due to the low rate of smoking among Iranian women
comparing to both Iranian men and American women.
Demonstration of this association requires further investi-
gation. Iranian women tend to have higher WHR compar-
ing to many other populations. Further studies are
necessary to elucidate the reasons for this finding as well
as the necessity of changing the definition of abdominal
obesity in Iran based on the distribution of WHR in Ira-
nian population. Prevalence of hypertension and diabetes
mellitus in our study was similar to the US population.
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